Test Price
2,800 AEDโ Home Collection Available
ATM Gene Ataxia-Telangiectasia (AโT) NGS Genetic Test in Dubai | 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Comprehensive ATM Gene Sequencing for Precision Diagnosis
- Accuracy Guarantee: >99.9% diagnostic sensitivity via ISO 15189 accredited next-generation sequencing (NGS) processing.
- Premium Logistics: Temperature-controlled VIP Mobile Phlebotomy and ISO-certified cold-chain home collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Confidential post-test telephonic consultation with a board-certified Consultant Medical Geneticist for result interpretation and family risk stratification.
- Insurance & Billing: Direct billing verification and transparent pricing available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced molecular diagnostic test provides comprehensive analysis of the ATM gene using Next-Generation Sequencing (NGS) technology. It is designed to detect pathogenic and likely pathogenic variants associated with Ataxia-Telangiectasia (AโT), a rare multisystem disorder, and to evaluate hereditary cancer predisposition, particularly for breast, ovarian, and lymphoid malignancies. The test is essential for neurologists, oncologists, and clinical geneticists developing targeted patient management plans.
| Feature | Our Test โ ATM NGS Panel | Closest Alternative โ Traditional Sanger |
|---|---|---|
| Precision | >99.9% analytical sensitivity; full gene coverage including deep intronic regions | Limited to targeted exons; high probability of missing deep intronic or mosaic variants |
| Methodology | Next-Generation Sequencing (NGS) with orthogonal Sanger confirmation | Sanger sequencing of hot-spot exons only |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
Physician Insight & Safety Protocols
โA genetic diagnosis of Ataxia-Telangiectasia carries profound implications for the patient and their entire family. My role is to ensure that the result is contextualized within a complete neurological examination and a three-generation pedigree analysis. We emphasize the importance of pre-test genetic counseling to address psychological readiness and post-test surveillance strategies for malignancy risk. Our commitment is to deliver not just a result, but a roadmap for care.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication & Clinical Advisory
- Do not discontinue any prescribed medication without consulting your doctor.
- Exclusion Criteria: Active infection affecting DNA integrity; unverified sample chain of custody; inability to provide informed consent.
- Minors: Parental or legal guardian consent is mandatory in compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Emergency Red Flags: Acute neurological deterioration, newโonset seizures, or signs of severe infection require immediate emergency medical care. This genetic test does not replace urgent clinical evaluation.
Patient FAQ & Clinical Guidance
1. What is the ATM gene test and who should consider it?
This test sequences the entire ATM gene to identify mutations that cause Ataxia-Telangiectasia or increase lifetime risks for breast, ovarian, and other cancers. It is recommended for individuals with a family history of AโT, those displaying cerebellar ataxia, oculocutaneous telangiectasias, or unexplained immunodeficiency, and for patients with early-onset breast cancer considering hereditary cancer panel evaluation.
2. How is the specimen collected and what is the turnaround time?
A standard peripheral blood draw, a dried blood spot on an FTA card, or a previously extracted DNA sample is collected by our certified mobile phlebotomy team under strict cold-chain conditions. Results are issued within 3 to 4 weeks via a secure digital report fully compliant with DHA standards.
3. Does a positive result mean I definitely have or will develop Ataxia-Telangiectasia?
A positive result indicates the presence of a pathogenic ATM variant but requires thorough clinical correlation by a Consultant Medical Geneticist or Neurologist. The diagnosis integrates biochemical markers (e.g., elevated alpha-fetoprotein), immunological findings, and neurological assessment. A positive genetic result significantly informs cancer risk surveillance and family cascade testing.
4. Will my insurance cover this genetic test?
Insurance coverage varies by policy. Our team can perform a direct billing verification against your plan. We also offer transparent self-pay pricing at 2,800 AED inclusive of genetic counseling and the comprehensive NGS analysis.
UAE Regulatory & Data Privacy Adherence
Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and processed in strict compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety, patient consent, and medical liability adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 15189 accreditation and operates under the direct regulatory oversight of the Dubai Health Authority (DHA).
Clinical & Logistical Metadata
| Test Name | ATM Gene Ataxia-Telangiectasia (AโT) NGS Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA), FTA Card Dried Blood Spot, or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) with Orthogonal Sanger Confirmation |
| ICD-10-CM Code | G11.3 (Ataxia-Telangiectasia), Z15.09 (Genetic Susceptibility to Malignant Neoplasm) |
| LOINC Code | 90388-3 (ATM gene mutation analysis) |
| DHA Facility License & Address |
License Number: 1143 Lab: DNA Labs UAE Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians